Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Carcinogenicity Tests MeSH Descriptor Data 2025


MeSH Heading
Carcinogenicity Tests
Tree Number(s)
E05.940.150
Unique ID
D015197
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D015197
Annotation
NIM; Manual 24.5.6.2+
Scope Note
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values.
Entry Term(s)
Carcinogen Tests
Carcinogenesis Tests
Carcinogenic Activity Tests
Carcinogenic Potency Tests
Tumorigenicity Tests
NLM Classification #
QZ 202
Previous Indexing
Carcinogens (1966-1988)
Mutagenicity Tests (1981-1988)
See Also
Mutagenicity Tests
Public MeSH Note
89
History Note
89
Date Established
1989/01/01
Date of Entry
1988/04/23
Revision Date
1994/05/12
Carcinogenicity Tests Preferred
page delivered in 0.143s